Advertising

Wednesday, May 16, 2012 - Page updated at 10:00 a.m.

Carlos Alberto Villegas, who developed dementia, is tended by his wife, Blanca Nelly Betancur, in Medellín, Colombia, on Feb. 5, 2010. Their family is a major component of a clinical drug trial that could lead to treatments that could prevent Alzheimer's disease before symptoms arise.

Enlarge this photoTODD HEISLER / NYT

Carlos Alberto Villegas, who developed dementia, is tended by his wife, Blanca Nelly Betancur, in Medellín, Colombia, on Feb. 5, 2010. Their family is a major component of a clinical drug trial that could lead to treatments that could prevent Alzheimer's disease before symptoms arise. Read story

UPDATE - 7:47 AM

Prevention is goal of Alzheimer's drug trial

The $100 million study will run for five years, but results on sophisticated tests may indicate in as little as two years whether a new drug, Crenezumab, is helping to delay memory decline or brain changes.

Recent stories

Monday, May 14

Afghan TV network may miss NATO summit on nation's future

An appropriate way to honor landmark tree's caretaker, 103

Proposed underwater power line to serve wind farms moves ahead

Senators see ballooning national crisis: helium shortage

Struggling California expecting $1.5B in taxes from Facebook IPO

U.S. trains African soldiers to gain upper hand in war-torn Somalia

Advertising

Advertising

Advertising

Advertising